AMLP vs. SBIO
Compare and contrast key facts about Alerian MLP ETF (AMLP) and ALPS Medical Breakthroughs ETF (SBIO).
AMLP and SBIO are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. AMLP is a passively managed fund by SS&C that tracks the performance of the Alerian MLP Infrastructure Index. It was launched on Aug 23, 2010. SBIO is a passively managed fund by SS&C that tracks the performance of the S-Network Medical Breakthroughs Index. It was launched on Dec 31, 2014. Both AMLP and SBIO are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
AMLP vs. SBIO - Performance Comparison
Loading graphics...
AMLP vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AMLP Alerian MLP ETF | 13.01% | 5.78% | 22.76% | 21.40% | 25.47% | 39.09% | -32.26% | 5.99% | -12.67% | -7.89% |
SBIO ALPS Medical Breakthroughs ETF | 3.20% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
Returns By Period
In the year-to-date period, AMLP achieves a 13.01% return, which is significantly higher than SBIO's 3.20% return. Over the past 10 years, AMLP has underperformed SBIO with an annualized return of 8.52%, while SBIO has yielded a comparatively higher 9.75% annualized return.
AMLP
- 1D
- -1.04%
- 1M
- -1.12%
- YTD
- 13.01%
- 6M
- 15.79%
- 1Y
- 8.11%
- 3Y*
- 19.85%
- 5Y*
- 20.13%
- 10Y*
- 8.52%
SBIO
- 1D
- 0.99%
- 1M
- 3.89%
- YTD
- 3.20%
- 6M
- 36.23%
- 1Y
- 95.78%
- 3Y*
- 26.37%
- 5Y*
- 1.76%
- 10Y*
- 9.75%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
AMLP vs. SBIO - Expense Ratio Comparison
AMLP has a 0.90% expense ratio, which is higher than SBIO's 0.50% expense ratio.
Return for Risk
AMLP vs. SBIO — Risk / Return Rank
AMLP
SBIO
AMLP vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alerian MLP ETF (AMLP) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AMLP | SBIO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.51 | 2.92 | -2.42 |
Sortino ratioReturn per unit of downside risk | 0.75 | 3.57 | -2.82 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.45 | -0.34 |
Calmar ratioReturn relative to maximum drawdown | 0.62 | 5.66 | -5.04 |
Martin ratioReturn relative to average drawdown | 1.57 | 19.94 | -18.37 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| AMLP | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.51 | 2.92 | -2.42 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.00 | 0.05 | +0.95 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.31 | 0.29 | +0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | 0.23 | -0.01 |
Correlation
The correlation between AMLP and SBIO is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
AMLP vs. SBIO - Dividend Comparison
AMLP's dividend yield for the trailing twelve months is around 7.62%, while SBIO has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMLP Alerian MLP ETF | 7.62% | 8.36% | 7.70% | 7.86% | 7.70% | 8.55% | 12.31% | 9.12% | 9.29% | 7.97% | 8.09% | 9.84% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% | 0.00% |
Drawdowns
AMLP vs. SBIO - Drawdown Comparison
The maximum AMLP drawdown since its inception was -77.19%, which is greater than SBIO's maximum drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for AMLP and SBIO.
Loading graphics...
Drawdown Indicators
| AMLP | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.19% | -63.06% | -14.13% |
Max Drawdown (1Y)Largest decline over 1 year | -14.27% | -15.08% | +0.81% |
Max Drawdown (5Y)Largest decline over 5 years | -20.92% | -53.67% | +32.75% |
Max Drawdown (10Y)Largest decline over 10 years | -72.62% | -63.06% | -9.56% |
Current DrawdownCurrent decline from peak | -3.20% | -13.79% | +10.59% |
Average DrawdownAverage peak-to-trough decline | -17.57% | -28.70% | +11.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.61% | 4.28% | +1.33% |
Volatility
AMLP vs. SBIO - Volatility Comparison
The current volatility for Alerian MLP ETF (AMLP) is 3.09%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 12.61%. This indicates that AMLP experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| AMLP | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.09% | 12.61% | -9.52% |
Volatility (6M)Calculated over the trailing 6-month period | 7.94% | 22.09% | -14.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.12% | 33.43% | -17.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.17% | 33.55% | -13.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.84% | 33.34% | -5.50% |